SQLE-IN-1

CAS No. 1019169-83-5

SQLE-IN-1( —— )

Catalog No. M37352 CAS No. 1019169-83-5

SQLE-IN-1 is a squalene epoxidase (SQLE) inhibitor with anti-tumor activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 37 In Stock
5MG 217 In Stock
10MG 353 In Stock
25MG 692 In Stock
50MG 1079 In Stock
100MG 1609 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    SQLE-IN-1
  • Note
    Research use only, not for human use.
  • Brief Description
    SQLE-IN-1 is a squalene epoxidase (SQLE) inhibitor with anti-tumor activity.
  • Description
    SQLE-IN-1 is a squalene epoxidase (SQLE) inhibitor with anti-tumor activity. It can inhibit the proliferation and migration of liver cancer cell line Huh7, inhibit the production of cellular cholesterol, and increase the expression of the tumor suppressor gene PTEN. expression, inhibiting the protein expression of PI3K and AKT.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Microbiology/Virology
  • Target
    Antifungal
  • Recptor
    Antifungal
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1019169-83-5
  • Formula Weight
    481.52
  • Molecular Formula
    C24H21F2N5O2S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=S(=O)(NC1=CC=C(C=C1)NC=2N=C(N=C(C2)NC3=CC=C(C=C3)C)C)C4=CC=C(F)C=C4F
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Neticonazole

    Neticonazole (SS717) is an imidazole derivative with antifungal activity that inhibits exosome secretion.

  • Neticonazole Hydroch...

    Neticonazole Hydrochloride is an imidazole antifungal for the treatment of fungal skin infections. Neticonazole is reported as a potent exosome inhibitor which can block the activity of exosomes.

  • APX2039

    APX2039 is an orally active fungal Gwt1 enzyme inhibitor and a prodrug of the novel Gwt2096 inhibitor APX1.APX2039 exhibits potent anti-Kryptococcal activity against C. neoformans and C. gattii.